Adamas Pharmaceuticals Inc
ADMSDelisted Nov 24, 2021- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001328143
Adamas Pharmaceuticals Inc was delisted on Nov 24, 2021; its insiders filed their last Form 4 on Nov 24, 2021; 63 institutions reported holding it in 13F filings for Q3 2021, worth $147.6M in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 63
- Q3 2021, −4 vs. previous quarter
- 13F value
- $147.6M
- Reported value at the end of Q3 2021
- Superinvestors holding
- 0
- At the end of Q3 2021
Superinvestors holding ADMS, Q3 2021
No superinvestor reported holding ADMS at the end of Q3 2021.
Latest insider trades
Open-market purchases and sales by Adamas Pharmaceuticals Inc insiders from Form 4, newest first.
No open-market purchases or sales by Adamas Pharmaceuticals Inc insiders are on file.
Top 10 13F holders, Q3 2021
The largest institutional positions in Adamas Pharmaceuticals Inc at the end of Q3 2021; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 5,449,340 | $26.8M | 0.00% | +176,940+3.4% | Added |
| Armistice Capital, LLC | 4,000,000 | $19.6M | 0.49% | +144,000+3.7% | Added |
| Stonepine Capital Management, LLC | 3,914,938 | $19.2M | 8.75% | +1,220,643+45.3% | Added |
| AIGH Capital Management LLC | 2,585,743 | $12.7M | 3.76% | +150,000+6.2% | Added |
| Vanguard Group Inc | 1,765,031 | $8.67M | 0.00% | +13,211+0.8% | Added |
| Swedbank AB | 1,485,000 | $7.29M | 0.01% | 00.0% | Unchanged |
| Opaleye Management Inc. | 1,460,000 | $7.17M | 1.34% | −210,600−12.6% | Reduced |
| Point72 Asset Management, L.P. | 1,150,000 | $5.65M | 0.03% | −1,101,255−48.9% | Reduced |
| Cooper Creek Partners Management LLC | 800,100 | $3.93M | 0.53% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 763,212 | $3.75M | 0.00% | −19,600−2.5% | Reduced |